Related Experiment Video
Updated: Feb 6, 2026

Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice
Published on: July 25, 2014
mTORC2 deficiency in cutaneous dendritic cells potentiates CD8+ effector T cell responses and accelerates skin graft
Alicia R Watson1,2, Helong Dai1,3, Julio A Diaz-Perez4
1Department of Surgery, Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Abstract:
Mechanistic target of rapamycin (mTOR) complex (mTORC)1 and mTORC2 regulate the differentiation and function of immune cells. While inhibition of mTORC1 antagonizes dendritic cell (DC) differentiation and suppresses graft rejection, the role of mTORC2 in DCs in determining host responses to transplanted tissue remains undefined. Using a mouse model in which mTORC2 was deleted specifically in CD11c+ DCs (TORC2DC-/- ), we show that the transplant of minor histocompatibility Ag (HY)-mismatched skin grafts from TORC2DC-/- donors into wild-type recipients results in accelerated rejection characterized by enhanced CD8+ T cell responses in the graft and regional lymphoid tissue [Correction added on January 9, 2019, after first online publication: in the previous sentence, major was changed to minor]. Similar enhancement of CD8+ effector T cell responses was observed in MHC-mismatched recipients of TORC2DC-/- grafts. Augmented CD8+ T cell responses were also observed in a delayed-type hypersensitivity model in which mTORC2 was absent in cutaneous DCs. These elevated responses could be ascribed to an increased T cell stimulatory phenotype of TORC2DC-/- and not to enhanced lymph node homing of the cells. In contrast, rejection of ovalbumin transgenic skin grafts in TORC2DC-/- recipients was unaffected. These findings suggest that mTORC2 in skin DCs restrains effector CD8+ T cell responses and have implications for understanding of the influence of mTOR inhibitors that target mTORC2 in transplant.
Insights
Mechanistic target of rapamycin complex 2 (mTORC2) in dendritic cells restrains CD8+ T cell responses. Deleting mTORC2 in dendritic cells accelerates skin graft rejection by enhancing T cell immunity.
Area of Science:
- Immunology
- Cell Biology
- Transplantation Science
Background:
- Mechanistic target of rapamycin (mTOR) complexes 1 and 2 (mTORC1 and mTORC2) are critical regulators of immune cell differentiation and function.
- While mTORC1 inhibition impacts dendritic cell (DC) differentiation and graft rejection, mTORC2's role in DCs regarding transplanted tissue responses is unclear.
Purpose of the Study:
- To investigate the role of mTORC2 specifically in CD11c+ dendritic cells (DCs) in the context of immune responses to transplanted tissues.
- To determine how the absence of mTORC2 in DCs influences T cell responses and graft rejection.
Main Methods:
- Utilized a mouse model with mTORC2 specifically deleted in CD11c+ DCs (TORC2DC-/-).
- Assessed the rejection of minor histocompatibility antigen (HY)-mismatched and MHC-mismatched skin grafts from TORC2DC-/- donors into wild-type recipients.
- Evaluated CD8+ T cell responses in grafts and lymphoid tissues.
- Examined a delayed-type hypersensitivity model with mTORC2-deficient cutaneous DCs.
- Compared responses using ovalbumin transgenic skin grafts in TORC2DC-/- recipients.
Main Results:
- Transplantation of skin grafts from TORC2DC-/- donors into wild-type recipients led to accelerated rejection.
- This accelerated rejection was associated with enhanced CD8+ T cell responses in the graft and regional lymphoid tissue.
- Similar augmentation of CD8+ effector T cell responses was observed in MHC-mismatched recipients.
- Increased T cell stimulatory capacity of TORC2DC-/- DCs, not enhanced lymph node homing, accounted for the elevated responses.
- Rejection of ovalbumin transgenic skin grafts in TORC2DC-/- recipients was not affected.
Conclusions:
- mTORC2 signaling within skin dendritic cells acts as a brake on effector CD8+ T cell responses.
- These findings have significant implications for understanding the impact of mTOR inhibitors targeting mTORC2 in transplantation settings.
Related Concept Videos
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
Neurons: The Cell Body and the Dendrites
Renewal of Skin Epidermal Stem Cells
Diversity in Cell Signaling Responses
Graded and Abrupt Responses
Some signaling systems generate...
Cell-mediated Immune Responses
Cells of the Adaptive Immune Response

